We are live on ! Find out more
NA

Neuburgh Advisers Portfolio holdings

AUM $3.22B
1-Year Est. Return 3.74%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+3.74%
3 Year Est. Return
+55.12%
5 Year Est. Return
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$165M
Cap. Flow
+$95.7M
Cap. Flow %
3.08%
Top 10 Hldgs %
25.98%
Holding
938
New
28
Increased
354
Reduced
207
Closed
26

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$16.8M
2
SNA icon
Snap-on
SNA
+$12.1M
3
AAPL icon
Apple
AAPL
+$11.3M
4
DD icon
DuPont de Nemours
DD
+$10.4M
5
BNY
Bank of New York Mellon
BNY
+$9.14M

Sector Composition

Rank Sector Weight
1 Healthcare 19.09%
2 Financials 15.65%
3 Technology 15.03%
4 Consumer Discretionary 11.67%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
901
Aquestive Therapeutics
AQST
$463M
$10K ﹤0.01%
2,332
CYCN icon
902
Cyclerion Therapeutics
CYCN
$14.9M
$10K ﹤0.01%
+44
New +$12.5K
ESTC icon
903
Elastic
ESTC
$6.84B
$10K ﹤0.01%
136
-340
-71% -$27.8K
NTNX icon
904
Nutanix
NTNX
$16B
$9K ﹤0.01%
336
-720
-68% -$25.1K
TBPH icon
905
Theravance Biopharma
TBPH
$874M
$8K ﹤0.01%
484
CLDR
906
DELISTED
Cloudera, Inc.
CLDR
$7K ﹤0.01%
1,364
ESLT icon
907
Elbit Systems
ESLT
$37.9B
$6K ﹤0.01%
44
VCIT icon
908
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$6K ﹤0.01%
64
BPY
909
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$6K ﹤0.01%
340
CRNX icon
910
Crinetics Pharmaceuticals
CRNX
$8.84B
$4K ﹤0.01%
160
ALNA
911
DELISTED
Allena Pharmaceuticals
ALNA
$4K ﹤0.01%
986
PTE
912
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
6
AR icon
913
Antero Resources
AR
$11.1B
-13,838
Closed -$122K
BURL icon
914
Burlington
BURL
$23.2B
-7,264
Closed -$1.14M
CUBE icon
915
CubeSmart
CUBE
$9.39B
-1,568
Closed -$50K
KYNB
916
Kyntra Bio
KYNB
$27.2M
-41
Closed -$56K
HEI icon
917
HEICO Corp
HEI
$49.8B
-528
Closed -$50K
HXL icon
918
Hexcel
HXL
$7.79B
-4,000
Closed -$277K
LHX icon
919
L3Harris
LHX
$51.6B
-44,302
Closed -$7.08M
MTCH icon
920
Match Group
MTCH
$9.19B
-1,904
Closed -$108K
PBI icon
921
Pitney Bowes
PBI
$2.37B
-14,624
Closed -$101K
ST icon
922
Sensata Technologies
ST
$6.74B
-1,716
Closed -$77K
TTSH
923
DELISTED
Tile Shop Holdings
TTSH
-7,040
Closed -$40K
XBI icon
924
State Street SPDR S&P Biotech ETF
XBI
$9.95B
-22
Closed -$2K
XPH icon
925
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
-792
Closed -$33K

Similar funds

Neuburgh Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Neuburgh Advisers held 938 positions worth $3.11B, up 5.6% from $2.94B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Neuburgh Advisers deployed $95.7M of net new capital in Q2 2019, opening 28 new positions and adding to 354 existing holdings. Its largest new stake was Dow Inc: 46,716 shares worth $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was RTX Corp, an estimated $16.8M trimmed.

  • Neuburgh Advisers's largest Q2 2019 buy was Dow Inc: 46,716 shares worth $2.3M.
  • Neuburgh Advisers added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $48.6M increase.
  • Neuburgh Advisers's biggest Q2 2019 reduction was RTX Corp, cutting an estimated $16.8M.
  • Neuburgh Advisers fully exited L3Harris in Q2 2019, selling an estimated $7.08M.
  • Neuburgh Advisers's ten largest holdings make up 26% of its $3.11B portfolio in Q2 2019.
  • Neuburgh Advisers opened 28 new positions and closed 26 in Q2 2019.
  • Neuburgh Advisers's portfolio value rose 5.6% quarter-over-quarter to $3.11B.

Based on Neuburgh Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.